Peptic Ulcer Disease
-
Evaluation
-
General—lesion of the mucous membrane lining the stomach or duodenum
-
Clinical—epigastric pain (aching, gnawing) that can be intermittent, dyspepsia, with or without nausea/vomiting
-
Gastric ulcer—pain occurs minutes after eating and can last for hours (until stomach is empty).
-
Duodenal ulcer—pain relieved by eating, but may return up to 4 hours later.
-
-
Etiology—many factors are associated with peptic ulcer disease (PUD), although these are the most common
-
Helicobacter pylori infection—acts by inducing mucosal inflammation and cytokine release.
-
Nonsteroidal anti-inflammatory drug (NSAID)/aspirin use— acts by inhibiting prostaglandin synthesis, which protects mucosa.
-
Those who use these agents are also at increased risk of complicated ulcers, bleeding, and so on.
-
-
-
Epidemiology—8% to 14% lifetime prevalence with complicating ulcer disease occurring with increased age
-
-
Advanced age (age older than70 years)
-
History of PUD or complicated ulcer disease
-
Concomitant warfarin or corticosteroid administration
-
Smokers—These individuals having impaired ulcer healing
-
Alcohol—unclear effect on patients without coexisting liver disease
-
-
Diagnostic algorithm—typically encompasses the differential of dyspepsia (see Chapter 2.24)
-
-
Treatment
-
H. pylori-related PUD
Stay updated, free articles. Join our Telegram channel
-

Full access? Get Clinical Tree

